fluoxetine has been researched along with amphetamine in 49 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (24.49) | 18.7374 |
| 1990's | 14 (28.57) | 18.2507 |
| 2000's | 10 (20.41) | 29.6817 |
| 2010's | 13 (26.53) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caron, G; Ermondi, G | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Bertekap, R; Bronson, J; Davis, C; He, H; Lelas, S; Macor, JE; Newton, A; Taber, M; Wallace, T; Westphal, R; Wu, YJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Callaway, CW; Geyer, MA | 1 |
| Basbaum, AI; Brown, JL; Matos, FF; Rollema, H | 1 |
| Gale, K; Meloni, R | 1 |
| Callaway, CW; Geyer, MA; Wing, LL | 1 |
| Goldberg, SR; Goodman, NL; Kuhar, MJ; Porrino, LJ; Ritz, MC; Sharpe, LG | 1 |
| Flood, JF; Morley, JE | 1 |
| Maickel, RP; Spratto, GR; Tocco, DR | 1 |
| Smith, DF | 1 |
| Izenwasser, S; Kornetsky, C | 1 |
| Poshivalov, VP; Valdman, AV | 1 |
| Snoddy, AM; Tessel, RE | 2 |
| Jenner, P; Kelly, E; Marsden, CD | 1 |
| Feldman, RS; McElroy, JF | 1 |
| Eisenberg, RM; Knych, ET | 1 |
| Dalló, J; Knoll, J; Yen, TT | 1 |
| Fuller, RW; Hemrick-Luecke, SK; Snoddy, HD | 1 |
| Blue, P; Glue, P | 1 |
| Barrett, J; Fahy, T; Meehan, O | 1 |
| Ichikawa, J; Kuroki, T; Meltzer, HY | 1 |
| Aunis, D; Burgun, C; Humblot, N; Thiriet, N; Zwiller, J | 1 |
| Bustos, SG; Lacerra, C; Martijena, ID; Molina, VA | 1 |
| Baker, GB; Fletcher, PJ; Greenshaw, AJ; Sills, TL | 3 |
| Campbell, TC; King, JM; Levitsky, DA; Lin, X | 1 |
| Koob, GF; Lin, D; Markou, A | 1 |
| Li, J; Ordway, GA; Shamburger, S; Zhu, MY | 1 |
| Harrison, AA; Liem, YT; Markou, A | 1 |
| Dalvi, A; Hen, R; Lucki, I; Mayorga, AJ; Page, ME; Zimov-Levinson, S | 1 |
| Gnegy, M; Kantor, L; Park, YH; Wang, KK | 1 |
| Baba, A; Hashimoto, H; Shintani, N; Tanaka, K | 1 |
| de Boissezon, X; de Boysson, C; Démonet, JF; Peran, P | 1 |
| Bespalov, AY; Gross, G; Mezler, M; Schoemaker, H; Sukhotina, IA; van Gaalen, MM; Wicke, K | 1 |
| Ma, Q; Spealman, RD; Xu, TX; Yao, WD | 1 |
| Desai, A; Fraser, R; Gnegy, ME; Guptaroy, B; Zhang, M | 1 |
| Ahlbrand, R; Bronson, SL; Grainger, M; Horn, P; McNamara, RK; Richtand, NM; Tambyraja, R | 1 |
| Caricati-Neto, A; da Silva Júnior, ED; de Souza, BP; Drawanz Pereira, J; Ferreira Verde, L; Jurkiewicz, A; Jurkiewicz, NH; Mendes Sobrinho, C; Miranda-Ferreira, R; Soubhi Smaili, S | 1 |
| Achterberg, EJ; Schoffelmeer, AN; Schrama, L; Siviy, SM; Trezza, V; Vanderschuren, LJ | 1 |
| Harro, J; Kõiv, K; O'Leary, A; Raudkivi, K | 1 |
| Hales, CA; Houghton, CJ; Robinson, ESJ | 1 |
| Harro, J; Kaldmäe, M; Kõiv, K; Laugus, K; Metelitsa, M; Shimmo, R; Tiitsaar, K; Vares, M | 1 |
| Kasprzyk-Hordern, B; Mrazova, J; Petrie, B; Yates, K | 1 |
2 review(s) available for fluoxetine and amphetamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pharmacotherapy of aphasia: myth or reality?
Topics: Amphetamine; Aphasia; Bromocriptine; Cholinesterase Inhibitors; Clinical Trials as Topic; Donepezil; Dopamine Agents; Fluoxetine; GABA Agonists; Humans; Indans; Neuroprotective Agents; Paroxetine; Physostigmine; Piperidines; Piracetam; Pyridines; Selective Serotonin Reuptake Inhibitors; Serotonin; Stroke; Zolpidem | 2007 |
47 other study(ies) available for fluoxetine and amphetamine
| Article | Year |
|---|---|
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water | 2005 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Discovery of disubstituted piperidines and homopiperidines as potent dual NK1 receptor antagonists-serotonin reuptake transporter inhibitors for the treatment of depression.
Topics: Antidepressive Agents; Astrocytes; Cell Line; HEK293 Cells; Humans; Neurokinin-1 Receptor Antagonists; Piperidines; Receptors, Neurokinin-1; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Structure-Activity Relationship | 2013 |
Stimulant effects of 3,4-methylenedioxymethamphetamine in the nucleus accumbens of rat.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Animals; Behavior, Animal; Corpus Striatum; Fluoxetine; Male; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Nucleus Accumbens; Rats; Rats, Inbred Strains | 1992 |
Do opioids evoke the release of serotonin in the spinal cord? An in vivo microdialysis study of the regulation of extracellular serotonin in the rat.
Topics: Amphetamine; Animals; Dialysis; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Extracellular Space; Fluoxetine; Hydroxyindoleacetic Acid; Injections, Intraventricular; Male; Morphine; Narcotics; Potassium Chloride; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, mu; Serotonin; Spinal Cord; Tetrodotoxin | 1992 |
Cocaine-induced turning behavior in rats with 6-hydroxydopamine lesions: effect of transplants of fetal substantia nigra.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Brain Diseases; Brain Tissue Transplantation; Cocaine; Dopamine; Fetal Tissue Transplantation; Fluoxetine; Imipramine; Male; Neural Pathways; Neurotransmitter Uptake Inhibitors; Nomifensine; Oxidopamine; Piperazines; Rats; Rats, Inbred Strains; Substantia Nigra | 1991 |
Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamines; Animals; Dose-Response Relationship, Drug; Drug Interactions; Fenclonine; Fluoxetine; Gait; Injections, Subcutaneous; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred Strains; Serotonin | 1990 |
Differential effects of the pharmacological manipulation of serotonin systems on cocaine and amphetamine self-administration in rats.
Topics: Amphetamine; Animals; Cinanserin; Cinnamates; Cocaine; Fluoxetine; Male; Rats; Rats, Inbred Strains; Reinforcement Schedule; Self Administration; Serotonin | 1989 |
An investigation of tolerance to the actions of leptogenic and anorexigenic drugs in mice.
Topics: Amphetamine; Animals; Appetite Depressants; Body Weight; Calcitonin; Dextroamphetamine; Drug Tolerance; Eating; Fluoxetine; Mice; Morphine; Naltrexone; Neurotransmitter Agents | 1987 |
Differential analgetic actions of amphetamine enantiomers in the mouse: a drug-drug interaction study.
Topics: Amphetamine; Analgesics; Animals; Dextroamphetamine; Dopamine; Drug Interactions; Fenclonine; Fluoxetine; Male; Metergoline; Mice; Morphine; Naloxone; Norepinephrine; Pimozide; Serotonin; Stereoisomerism | 1985 |
The stereoselectivity of serotonin uptake in brain tissue and blood platelets: the topography of the serotonin uptake area.
Topics: Alanine; Amphetamine; Aniline Compounds; Animals; Antidepressive Agents; Blood Platelets; Brain; Fluoxetine; Humans; Male; Methadone; Mianserin; Mirtazapine; Morpholines; Naphthalenes; Nefopam; Nomifensine; Paroxetine; Piperidines; Rabbits; Serotonin; Stereoisomerism; Tranylcypromine; Viloxazine; Zimeldine | 1986 |
Potentiation of morphine analgesia by D-amphetamine is mediated by norepinephrine and not dopamine.
Topics: Amphetamine; Analgesics; Animals; Dopamine; Dopamine Antagonists; Drug Synergism; Electric Stimulation; Escape Reaction; Fluoxetine; Morphine; Nalidixic Acid; Naphthyridines; Norepinephrine; Pain; Reaction Time; Reticular Formation | 1988 |
Pharmaco-ethological analysis of antidepressant drug effects.
Topics: Aggression; Amphetamine; Animals; Antidepressive Agents; Behavior, Animal; Fluoxetine; Imipramine; Iproniazid; Male; Mice; Motor Activity; Reserpine; Social Behavior; Trazodone | 1986 |
Prazosin: effect on psychomotor-stimulant cues and locomotor activity in mice.
Topics: Amphetamine; Animals; Cocaine; Cues; Discrimination, Psychological; Fluoxetine; Male; Mice; Mice, Inbred ICR; Motor Activity; Pimozide; Prazosin; Propranolol; Stereotyped Behavior | 1985 |
Evidence that [3H]dopamine is taken up and released from nondopaminergic nerve terminals in the rat substantia nigra in vitro.
Topics: Amphetamine; Animals; Catecholamines; Corpus Striatum; Desipramine; Dopamine; Female; Fluoxetine; Hydroxydopamines; Medial Forebrain Bundle; Nerve Endings; Nomifensine; Oxidopamine; Potassium Chloride; Raphe Nuclei; Rats; Rats, Inbred Strains; Serotonin; Substantia Nigra; Synaptosomes | 1985 |
Discriminative stimulus properties of fenfluramine: evidence for serotonergic involvement.
Topics: Amphetamine; Analysis of Variance; Animals; Cues; Discrimination Learning; Dose-Response Relationship, Drug; Fenfluramine; Fluoxetine; Generalization, Stimulus; Male; Rats; Receptors, Serotonin; Satiation; Stereoisomerism | 1984 |
Nisoxetine and amphetamine share discriminative stimulus properties in mice.
Topics: Amphetamine; Animals; Discrimination, Psychological; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Fluoxetine; Male; Mice; Mice, Inbred ICR; Premedication; Propylamines; Taste | 1983 |
Effect of fluoxetine and metergoline on amphetamine-induced rise in plasma corticosterone.
Topics: Amphetamine; Animals; Corticosterone; Ergolines; Fluoxetine; Kinetics; Male; Metergoline; Propylamines; Rats | 1980 |
The selectivity of the anorectic effect of satietin. IV. The ineffectiveness of satietin on the sexual performance of male CFY rats.
Topics: Amphetamine; Animals; Appetite Depressants; Copulation; Fenfluramine; Fluoxetine; Glycopeptides; Male; Rats; Time Factors | 1982 |
Fluoxetine at anorectic doses does not have properties of a dopamine uptake inhibitor.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Appetite Depressants; Brain Chemistry; Dopamine; Dopamine Uptake Inhibitors; Fluoxetine; Homovanillic Acid; Injections, Intraventricular; Male; Mazindol; Neostriatum; Oxidopamine; Rats; Rats, Sprague-Dawley | 1994 |
SSRI and sympathomimetic interaction.
Topics: Amphetamine; Arousal; Central Nervous System Stimulants; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme Inhibitors; Drug Synergism; Fluoxetine; Humans; Mixed Function Oxygenases; Selective Serotonin Reuptake Inhibitors; Sympathetic Nervous System | 1996 |
SSRI and sympathominetic interaction.
Topics: Adult; Amphetamine; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Fluoxetine; Humans; Male; Psychoses, Substance-Induced; Selective Serotonin Reuptake Inhibitors; Substance-Related Disorders; Sympathomimetics | 1996 |
Differential effects of chronic imipramine and fluoxetine on basal and amphetamine-induced extracellular dopamine levels in rat nucleus accumbens.
Topics: Amphetamine; Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Area Under Curve; Dopamine; Dopamine Uptake Inhibitors; Extracellular Space; Fluoxetine; Imipramine; Male; Microdialysis; Nucleus Accumbens; Rats; Rats, Sprague-Dawley | 1998 |
Cocaine and fluoxetine induce the expression of the hVH-5 gene encoding a MAP kinase phosphatase.
Topics: 5,7-Dihydroxytryptamine; Amphetamine; Animals; Caffeine; Central Nervous System Stimulants; Cocaine; Drug Interactions; Dual-Specificity Phosphatases; Enzyme Induction; Fluoxetine; Genes, Immediate-Early; Immediate-Early Proteins; Male; Nerve Tissue Proteins; Protein Tyrosine Phosphatases; Rats; Rats, Wistar | 1998 |
Benzodiazepine withdrawal facilitates the subsequent onset of escape failures and anhedonia: influence of different antidepressant drugs.
Topics: Amphetamine; Animals; Anti-Anxiety Agents; Antidepressive Agents; Avoidance Learning; Conditioning, Classical; Cues; Desipramine; Diazepam; Electroshock; Escape Reaction; Fluoxetine; Male; Odorants; Phenelzine; Rats; Sexual Behavior, Animal; Substance Withdrawal Syndrome; Time Factors | 1999 |
Acute fluoxetine treatment potentiates amphetamine hyperactivity and amphetamine-induced nucleus accumbens dopamine release: possible pharmacokinetic interaction.
Topics: Adrenergic Uptake Inhibitors; Amphetamine; Analysis of Variance; Animals; Dopamine; Drug Synergism; Fluoxetine; Male; Microdialysis; Motor Activity; Nucleus Accumbens; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors | 1999 |
The potentiating effect of sertraline and fluoxetine on amphetamine-induced locomotor activity is not mediated by serotonin.
Topics: Amphetamine; Analysis of Variance; Animals; Brain; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Drug Synergism; Fluoxetine; Locomotion; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Sertraline | 1999 |
The promotion effect of anorectic drugs on aflatoxin B(1)-induced hepatic preneoplastic foci.
Topics: Adipose Tissue, Brown; Aflatoxin B1; Amphetamine; Animals; Appetite Depressants; Biomarkers; Body Temperature Regulation; Carcinogens; Chemical and Drug Induced Liver Injury; Cocarcinogenesis; Dopamine; Drug Synergism; Eating; Energy Metabolism; Fenfluramine; Fluoxetine; gamma-Glutamyltransferase; Growth Disorders; Hypothyroidism; Liver Diseases; Liver Neoplasms, Experimental; Male; Organ Size; Precancerous Conditions; Rats; Rats, Inbred F344; Selective Serotonin Reuptake Inhibitors; Serotonin; Weight Loss | 1999 |
Differential effects of withdrawal from chronic amphetamine or fluoxetine administration on brain stimulation reward in the rat--interactions between the two drugs.
Topics: Amphetamine; Animals; Brain; Central Nervous System Stimulants; Drug Interactions; Fluoxetine; Male; Rats; Rats, Wistar; Reward; Selective Serotonin Reuptake Inhibitors; Self Stimulation; Substance Withdrawal Syndrome | 1999 |
Subchronic fluoxetine treatment induces a transient potentiation of amphetamine-induced hyperlocomotion: possible pharmacokinetic interaction.
Topics: Amphetamine; Animals; Brain; Central Nervous System Stimulants; Drug Synergism; Fluoxetine; Male; Motor Activity; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Stimulation, Chemical | 2000 |
Regulation of the human norepinephrine transporter by cocaine and amphetamine.
Topics: Amphetamine; Animals; Carrier Proteins; Cells, Cultured; Cocaine; Fluoxetine; Humans; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; PC12 Cells; Rats; RNA, Messenger; Symporters | 2000 |
Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats.
Topics: Aminopyridines; Amphetamine; Amphetamine-Related Disorders; Animals; Body Weight; Brain; Depression; Disease Models, Animal; Drug Combinations; Electric Stimulation; Fluoxetine; Male; Mecamylamine; Neurons; Nicotine; Nicotinic Antagonists; Piperazines; Rats; Rats, Wistar; Reaction Time; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Reward; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Substance Withdrawal Syndrome; Synaptic Transmission; Tobacco Use Disorder | 2001 |
Antidepressant-like behavioral effects in 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) receptor mutant mice.
Topics: alpha-Methyltyrosine; Amphetamine; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Behavior, Animal; Brain Chemistry; Catecholamines; Desipramine; Fenclonine; Fluoxetine; Mice; Motor Activity; Mutation; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents | 2001 |
Enhanced amphetamine-mediated dopamine release develops in PC12 cells after repeated amphetamine treatment.
Topics: Amphetamine; Animals; Dopamine; Fluoxetine; Nerve Growth Factor; PC12 Cells; Rats | 2002 |
[Altered behavioral response to centrally acting drugs in mice lacking PACAP].
Topics: Amphetamine; Animals; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Disease Models, Animal; Fluoxetine; Haloperidol; Mice; Mice, Knockout; Neuropeptides; Pituitary Adenylate Cyclase-Activating Polypeptide; Risperidone | 2003 |
Behavioral characterization of the mGlu group II/III receptor antagonist, LY-341495, in animal models of anxiety and depression.
Topics: Amino Acids; Amphetamine; Animals; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Anxiety; Behavior, Animal; Central Nervous System Stimulants; Conditioning, Operant; Darkness; Depression; Diazepam; Fever; Fluoxetine; Light; Male; Mice; Paroxetine; Receptors, Metabotropic Glutamate; Reinforcement Schedule; Stress, Psychological; Xanthenes | 2008 |
Amphetamine modulation of long-term potentiation in the prefrontal cortex: dose dependency, monoaminergic contributions, and paradoxical rescue in hyperdopaminergic mutant.
Topics: Amphetamine; Animals; Dopamine D2 Receptor Antagonists; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Excitatory Postsynaptic Potentials; Fluoxetine; Long-Term Potentiation; Mice; Mice, Inbred C57BL; Mice, Knockout; Mutation; Norepinephrine; Prefrontal Cortex; Receptors, Adrenergic, beta; Receptors, Dopamine D1; Receptors, Dopamine D2 | 2010 |
Site-directed mutations near transmembrane domain 1 alter conformation and function of norepinephrine and dopamine transporters.
Topics: Amphetamine; Benztropine; Binding Sites; Biotinylation; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Fluoxetine; HEK293 Cells; Humans; Immunoblotting; Mutagenesis, Site-Directed; Norepinephrine Plasma Membrane Transport Proteins; Pharmacokinetics; Protein Conformation | 2011 |
Fluoxetine and aripiprazole treatment following prenatal immune activation exert longstanding effects on rat locomotor response.
Topics: Acute-Phase Reaction; Amphetamine; Animals; Antipsychotic Agents; Aripiprazole; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Fluoxetine; Immune System; Male; Motor Activity; Piperazines; Poly I-C; Pregnancy; Prenatal Exposure Delayed Effects; Quinolones; Rats; Rats, Sprague-Dawley; Schizophrenia; Selective Serotonin Reuptake Inhibitors | 2012 |
Changes of cytosolic calcium and contractility of young rat vas deferens by acute treatment with amphetamine, fluoxetine or sibutramine.
Topics: Amphetamine; Animals; Calcium; Central Nervous System Agents; Cyclobutanes; Cytosol; Fluoxetine; Homeostasis; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Rats; Rats, Wistar; Time Factors; Vas Deferens | 2012 |
Amphetamine and cocaine suppress social play behavior in rats through distinct mechanisms.
Topics: Adrenergic Agents; Adrenergic alpha-2 Receptor Antagonists; Adrenergic Uptake Inhibitors; Amphetamine; Animals; Atomoxetine Hydrochloride; Behavior, Animal; Cocaine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Exploratory Behavior; Fluoxetine; Flupenthixol; Idazoxan; Male; Motor Activity; Piperazines; Play and Playthings; Propylamines; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Social Behavior | 2014 |
Antidepressants differentially affect striatal amphetamine-stimulated dopamine and serotonin release in rats with high and low novelty-oriented behaviour.
Topics: Amphetamine; Animals; Antidepressive Agents; Behavior, Animal; Corpus Striatum; Dopamine; Fluoxetine; Imipramine; Male; Microdialysis; Morpholines; Rats; Rats, Wistar; Reboxetine; Selective Serotonin Reuptake Inhibitors; Serotonin | 2016 |
Behavioural and computational methods reveal differential effects for how delayed and rapid onset antidepressants effect decision making in rats.
Topics: Acoustic Stimulation; Amphetamine; Analgesics; Animals; Antidepressive Agents; Association Learning; Central Nervous System Stimulants; Cocaine; Conditioning, Classical; Decision Making; Depressive Disorder, Major; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Fluoxetine; Ketamine; Male; Models, Biological; Phencyclidine; Rats; Reaction Time; Time Factors | 2017 |
Chronic stress sensitizes amphetamine-elicited 50-kHz calls in the rat: Dependence on positive affective phenotype and effects of long-term fluoxetine pretreatment.
Topics: Affect; Amino Acids; Amphetamine; Animals; Central Nervous System Sensitization; Fluoxetine; Frontal Lobe; Hippocampus; Individuality; Male; Rats; Rats, Inbred Strains; Serotonin; Stress, Psychological; Time Factors; Vocalization, Animal | 2018 |
Multi-residue analysis of chiral and achiral trace organic contaminants in soil by accelerated solvent extraction and enantioselective liquid chromatography tandem-mass spectrometry.
Topics: Amphetamine; Central Nervous System Stimulants; Chromatography, Liquid; Environmental Monitoring; Fluoxetine; Soil; Soil Pollutants; Solvents; Stereoisomerism; Tandem Mass Spectrometry | 2018 |